Compare Guardant Health Inc. Common Stock (GH) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Guardant Health Inc. Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Guardant Health Inc. Common Stock trades at $167.04 (market cap $22.22B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.07 (market cap $6.04B). The key difference: Guardant Health Inc. Common Stock is far larger — about 3.7× Iovance Biotherapeutics Inc. Common Stock's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Guardant Health Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Guardant Health Inc. Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| GH | IOVA | |
|---|---|---|
Market Cap | $22.22B | $6.04B |
Volume | 1,589,453 | 14,805,993 |
Sector | Health | Health |
52-Week High | $187.22 | $14.82 |
52-Week Low | $61.73 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $22.86B | $5.97B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Guardant Health Inc. Common Stock
Guardant Health develops blood tests for cancer care. Its tests support genomic profiling, cancer screening, recurrence monitoring, and treatment decisions.
Read more on GH →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
